adenosine modulators (King/Ferrara)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameadenosine modulators (King/Ferrara)
Drug Alias Nameadenosine modulators (King/Ferrara)PD-81723 derivatives (King/Ferrara)adenosine modulators (Medco/Ferrara)MRE-2029F20[3H]-MRE-3008-F20 +[7] 
ClassificationSmall molecules
Mechanisms of ActionAdenosine A1 receptor agonistsAdenosine A3 receptor antagonistsAdenosine A3 receptor agonists +[4] 
TargetsAdenosine A3 receptorAdenosine A1 receptor
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKing Pharmaceuticals Research And Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of FerraraKing Pharmaceuticals Research And Development Llc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A